CHE Earnings
Latest Revenue673.3M
Latest Net Income67.7M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $5.14 | 673.3M | 67.7M | +8.8% | +42.8% |
| Q1 2026 | $4.85 | 657.5M | 66.3M | +1.6% | -1.2% |
| Q4 2025 | $5.49 | 639.3M | 76.8M | -0.1% | -9.7% |
| Q3 2025 | $4.46 | 624.9M | 64.2M | +3.1% | -11.5% |
| Q2 2025 | $3.60 | 618.8M | 52.5M | +3.8% | -23.4% |
| Q1 2025 | $4.91 | 646.9M | 71.8M | +9.8% | +14.2% |
| Q4 2024 | $6.08 | 640.0M | 90.3M | +9.2% | +2.0% |
| Q3 2024 | $5.04 | 606.2M | 75.8M | +7.4% | +1.4% |
| Q2 2024 | $4.70 | 595.9M | 70.9M | — | — |
| Q1 2024 | $4.30 | 589.2M | 65.0M | — | — |
| Q4 2023 | $5.96 | 585.9M | 90.1M | — | — |
| Q3 2023 | $4.97 | 564.5M | 75.0M | — | — |
Chemed (CHE) — Earnings